Status:
UNKNOWN
Comparing Ciprofol and Propofol for Sedation in Hypotensive ICU Patients: a Single Center Prospective Cohort Study
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Ciprofol
Propofol
Eligibility:
All Genders
18+ years
Brief Summary
This study was a single-center, prospective, 2-year observational cohort study. The study subjects were ICU patients requiring vasopressor drugs and requiring sedation. According to the use of ciprofo...
Eligibility Criteria
Inclusion
- Age ≥ 18;
- It needs to be treated with vasopressors to maintain mean arterial pressure ≥65 mmHg;
- Sedative medication required for comfort, safety, and to facilitate life support measures;
- Obtain the informed consent of the human subjects or their legal representatives.
Exclusion
- Pregnant patient;
- Patients with proven acute severe intracranial or spinal neurological disease due to vascular, intracranial dilatation, or injury;
- History of allergy to cyclopofol, propofol, eggs, or soy products;
- History of long-term use of benzodiazepines or opioids;
- Sedative drugs other than propofol or cyclopofol were used at enrollment, or propofol and cyclopofol were used alternately within 24 hours;
- The researchers judged that they are not suitable to participate in this study.
Key Trial Info
Start Date :
October 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
456 Patients enrolled
Trial Details
Trial ID
NCT05971121
Start Date
October 1 2022
End Date
October 1 2024
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern medical university Nanfang hospital
Guangzhou, China, 510515